)

Black Diamond Therapeutics (BDTX) investor relations material
Black Diamond Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Entered a global licensing agreement with Servier for BDTX-4933, receiving a $70M upfront payment and eligibility for up to $710M in milestones and tiered royalties.
Lead program silevertinib advanced in Phase 2 trials for EGFRm NSCLC and GBM, with key data readouts expected in late 2025 and 2026.
Completed enrollment for Phase 2 silevertinib trial in 1L non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data expected Q4 2025.
Corporate restructuring and operational efficiencies led to significant reductions in R&D and G&A expenses year-over-year.
Cash, cash equivalents, and investments of $142.8M as of June 30, 2025, expected to fund operations into Q4 2027.
Financial highlights
Reported $70M in license revenue for the six months ended June 30, 2025, compared to none in the prior year period.
Net income of $46.0M for the six months ended June 30, 2025, versus a net loss of $38.1M year-over-year.
R&D expenses decreased to $19.8M from $26.1M, and G&A expenses fell to $9.1M from $16.3M for the six-month period.
Net loss for Q2 2025 was $10.6M, compared to $19.9M in Q2 2024.
Cash position increased to $142.8M at June 30, 2025, from $98.6M at December 31, 2024.
Outlook and guidance
Cash runway projected into Q4 2027 based on current plans and assumptions.
Initial results from frontline silevertinib Phase 2 cohort expected in Q4 2025; final results from recurrent setting anticipated in H1 2026.
Exploring partnership opportunities for silevertinib pivotal development and monitoring macroeconomic and regulatory changes.
Next Black Diamond Therapeutics earnings date

Next Black Diamond Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage